Open AccessCosts and Healthcare Resource Utilization Associated with Idarucizumab or Andexanet Alfa Oral Anticoagulant Reversal in Patients Hospitalized with Life-Threatening Bleeds
Author(s) -
Alex C. Spyropoulos,
Bríain ó Hartaigh,
Zhun Cao,
Harjeet Caberwal,
Craig Lipkin,
Michaela Petrini,
Cheng Wang
Publication year - 2022
Publication title -
clinical and applied thrombosis/hemostasis
Language(s) - English
Resource type - Journals
eISSN - 1938-2723
pISSN - 1076-0296
DOI - 10.1177/10760296221110568
Subject(s) - idarucizumab , medicine , health care , intensive care medicine , dabigatran , warfarin , atrial fibrillation , economics , economic growth
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom